Balanced news tone
News Sentiment
MDAI sentiment intelligence
Spectral AI Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
78/100 classification confidence.
directly relevant articles
high-authority source matches
-3.9% over one week, -5.5% over four weeks, trend active, and below fair value.
Spectral AI Inc. (MDAI) Holds Steady at $1.72 as Key Levels Define Trading Range - Volume Profile
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Reflecting On Medical Devices & Supplies - Specialty Stocks’ Q1 Earnings: Integer Holdings (NYSE:ITGR)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Jul 2026 18:07
- Source
- Market source
Spectral AI Inc. (MDAI) Holds Steady at $1.72 as Key Levels Define Trading Range - Volume Profile
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jul 2026 20:47
- Source
- dars.gov.et
Spectral AI (MDAI) hires Darcy Bajko as CCO to drive DeepView burn launch
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 20:02
- Source
- Stock Titan
Spectral AI Names Darcy Bajko Chief Commercial Officer to Lead Global Sales Launch of FDA-Cleared DeepView® System for Burn Indication
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 12:30
- Source
- GlobeNewswire
Spectral AI taps veteran marketer for FDA-cleared burn device rollout
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 07:00
- Source
- Stock Titan
Form 4 Spectral AI Inc For: 29 June By Investing.com
This article from Investing.com is a regulatory filing update, announcing the Form 4 for Spectral AI Inc. filed on June 29. It briefly mentions the company's stock symbol MDAI and contains links to view comments. The primary content of the article beyond this announcement appears
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 30 Jun 2026 16:10
- Source
- Investing.com South Africa
Spectral AI, Inc.(NasdaqCM: MDAI) added to Russell 3000E Value Benchmark
Spectral AI, Inc. (NasdaqCM: MDAI) has been added to the Russell 3000E Value Benchmark, effective June 28, 2026. This inclusion indicates the company's growing recognition in the financial markets. The article also provides recent news on Spectral AI, including executive appointm
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 07:12
- Source
- marketscreener.com
Spectral AI (MDAI) director DiMaio granted 44K shares, holds large RSU and option awards
Spectral AI, Inc. director John Michael DiMaio was granted 44,000 shares of common stock at prices ranging from $1.69 to $1.74 per share, increasing his direct holdings to over 2.7 million shares. He also holds significant equity incentives including restricted stock units for 10
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 02:39
- Source
- Stock Titan
Price to earnings forward of Spectral AI, Inc. – NASDAQ:MDAI
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Jun 2026 04:16
- Source
- TradingView
Spectral AI, Inc. Class A Actuals & Estimates (NASDAQ:MDAI)
This article provides an overview of Spectral AI, Inc. (MDAI) stock performance, analyst estimates, and financial data. It covers current stock price, historical highs and lows, volatility, market capitalization, and upcoming earnings dates. The information is presented in a Q&A
- Tone
- Negative 30/100
- Event
- Earnings
- Published
- 25 Jun 2026 18:11
- Source
- TradingView
Spectral AI Inc (MDAI) Earnings Forecast: Future EPS & Revenue Growth Estimates
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 21 Jun 2026 20:07
- Source
- TradingKey
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 15 Jun 2026 07:00
- Source
- StockStory
Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jun 2026 12:30
- Source
- GlobeNewswire
Spectral AI to Participate in 2026 British Burn Association Annual Conference
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 12:30
- Source
- GlobeNewswire
FDA clears Spectral AI (Nasdaq: MDAI) DeepView burn system as shareholders back all 2026 proposals
Spectral AI (MDAI) announced that its DeepView System for burn indication received FDA De Novo clearance, transitioning the company towards commercial deployment of its AI-driven wound diagnostics platform. Additionally, shareholders approved all proposals at the 2026 Annual Meet
- Tone
- Positive 74/100
- Event
- Market update
- Published
- 02 Jun 2026 15:10
- Source
- Stock Titan
Spectral AI (MDAI) director DiMaio reports new stock grants and options
Spectral AI (MDAI) director John Michael DiMaio reported receiving new stock grants and options. He was granted 15,000 shares of Common Stock on May 29, 2026, and 2,500 shares on May 28, 2026, increasing his direct Common Stock holdings to 2,687,847 shares. The filing also detail
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 04:40
- Source
- Stock Titan
Spectral AI Announces Voting Results of Annual Meeting of Stockholders
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 01 Jun 2026 12:00
- Source
- GlobeNewswire
AI burn-scan cleared by FDA as Spectral AI targets first sales
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- Stock Titan
Spectral AI Receives FDA De Novo Clearance for DeepView® System for Burn Indication
Spectral AI, Inc. announced that its DeepView® System received FDA De Novo Classification, allowing commercial distribution in the US for burn care. The DeepView System is a non-invasive, AI-powered device that uses multispectral imaging to assess the healing potential of burn wo
- Tone
- Positive 95/100
- Event
- Market update
- Published
- 29 May 2026 15:40
- Source
- Market source
Spectral AI (NASDAQ: MDAI) director granted 32,233 shares and holds options
Spectral AI (NASDAQ: MDAI) director John Michael DiMaio was granted 32,233 shares of common stock at $2.61 per share, increasing his direct holdings to 2,670,347 shares. The filing also detailed his outstanding equity awards, including restricted stock units for 100,000 shares an
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 May 2026 00:38
- Source
- Stock Titan
FDA clears Spectral AI (NASDAQ: MDAI) DeepView burn device
Spectral AI (NASDAQ: MDAI) has received FDA De Novo Classification for its DeepView System, authorizing commercial distribution in the U.S. for burn care. The DeepView System is a non-invasive device that uses multispectral imaging and AI to predict burn wound healing potential w
- Tone
- Positive 86/100
- Event
- Market update
- Published
- 27 May 2026 00:38
- Source
- Stock Titan
MDAI - Spectral AI: First of Its Kind Automated Wound Healing Prediction
Spectral AI (NASDAQ: MDAI) has received FDA approval for its DeepView AI Automated Wound Imaging System, a significant milestone for the company. This device provides AI-driven predictive diagnostics for wound healing, aiming to improve patient outcomes and reduce healthcare cost
- Tone
- Positive 82/100
- Event
- Regulatory and legal
- Published
- 26 May 2026 05:10
- Source
- Simply Wall Street
Spectral AI receives FDA De Novo clearance for burn wound system
Spectral AI, Inc. announced FDA De Novo Classification for its DeepView System, a non-invasive medical device that uses AI and multispectral imaging to assess burn wound healing potential. This clearance allows commercial distribution in the U.S. and follows an 88.73% year-to-dat
- Tone
- Positive 73/100
- Event
- Market update
- Published
- 24 May 2026 19:39
- Source
- Investing.com
BTIG raises Spectral AI stock price target to $4 on FDA clearance
BTIG has raised its price target for Spectral AI Inc. (NASDAQ:MDAI) to $4.00 from $3.00, maintaining a Buy rating, following the company's announcement of FDA clearance for its DeepView System. The system, designed for burn centers and emergency departments, is expected to launch
- Tone
- Positive 72/100
- Event
- Analyst action
- Published
- 24 May 2026 07:11
- Source
- Investing.com
Spectral AI (MDAI) director awarded 25,000 shares and reports vested options
Spectral AI (MDAI) director Sadagopan Deepak was awarded 25,000 shares of common stock at no cost on April 24, 2026, increasing his directly held common shares to 25,000. He also holds 25,000 fully vested restricted stock units and various non-qualified stock options with strike
- Tone
- Positive 59/100
- Event
- Market update
- Published
- 21 May 2026 09:12
- Source
- Stock Titan
Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 May 2026 07:00
- Source
- Market source
Spectral AI (NASDAQ: MDAI) director granted additional common shares and options
Richard John Cotton, a director at Spectral AI (NASDAQ: MDAI), was granted additional stock-based compensation. He received 8,818 common shares at $2.40 each and 5,882 shares at $2.33 each, increasing his direct common share holdings to 111,477. The filing also details his existi
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 May 2026 20:39
- Source
- Stock Titan
Spectral AI (MDAI) director granted additional common shares and options
Spectral AI (MDAI) director John Michael DiMaio reported receiving new equity compensation, including grants of 25,000 and 1,887 common shares at $2.16 and $2.12 per share, respectively. Following these transactions on May 15, 2026, his direct holdings increased to 2,638,114 comm
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 May 2026 20:39
- Source
- Stock Titan
Analyst Estimates: Here's What Brokers Think Of Spectral AI, Inc. (NASDAQ:MDAI) After Its First-Quarter Report
Spectral AI, Inc. (NASDAQ:MDAI) missed analyst expectations in its first-quarter report, with revenues slightly below forecasts and statutory earnings significantly lower. Following these results, analysts maintained their revenue forecasts for 2026 but increased per-share loss e
- Tone
- Negative 39/100
- Event
- Earnings
- Published
- 15 May 2026 08:40
- Source
- Sahm
Spectral AI (NASDAQ: MDAI) Q1 2026 revenue falls 40% as BARDA work shifts
Spectral AI reported a 40.5% decrease in Q1 2026 research and development revenue, totaling $3.99 million, primarily due to a slowdown in BARDA contract activities as the base phase neared completion. Despite the revenue decline, the company saw an improvement in gross margin to
- Tone
- Negative 29/100
- Event
- Earnings
- Published
- 13 May 2026 21:39
- Source
- Stock Titan